FDA approves Zargis' Signal X6 heart scanner

FDA approves heart scanner made by Speedus subsidiary Zargis; Speedus reaches three-year high

• On 10:37 am EDT, Thursday September 17, 2009

STAMFORD, Conn. (AP) -- Zargis Medical Corp. said Thursday the Food and Drug Administration has approved its Signal X6 heart and lung scanner, which can take cardiac scans and transmit them through the Internet to specialists.

The device records signals from the heart and lungs through six sensors. The data can be viewed on site, but can also be transmitted if there are no cardiac specialists nearby. Zargis said that after the approval, it delivered seven Signal X6s to the U.S. Army. The sensors will be used in six Department of Defense medical facilities.

Zargis was spun off from Siemens, and is majority owned by Speedus Corp. In morning trading, Speedus shares more than doubled to $7.30, up $4.05, and reached a three-year high of $8.57.